Ligand validation:5EXK

MET: METHIONINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5EXK_MET_A_404	98%	37%	0.067	0.99	0.88	1.56	1	2	0	0	100%	1
5EXK_MET_C_404	98%	36%	0.066	0.988	0.91	1.57	1	2	0	0	100%	1
5EXK_MET_K_404	97%	42%	0.067	0.981	0.9	1.35	1	2	0	0	100%	1
5EXK_MET_E_404	97%	40%	0.072	0.986	0.89	1.45	1	2	0	0	100%	1
5EXK_MET_I_404	96%	41%	0.072	0.981	0.94	1.34	1	2	0	0	100%	1
5EXK_MET_G_404	80%	28%	0.109	0.957	0.98	1.88	1	2	0	0	100%	1
3AYL_MET_A_905	99%	42%	0.048	0.984	1.31	0.94	1	-	1	0	100%	1
3IIX_MET_A_1401	99%	51%	0.056	0.989	0.78	1.09	-	1	0	0	100%	1
5URB_MET_A_603	99%	43%	0.06	0.989	0.94	1.27	1	2	0	0	100%	1
5FEZ_MET_A_409	97%	62%	0.066	0.979	0.5	0.95	-	-	0	0	100%	1
7MJX_MET_B_605	96%	46%	0.077	0.988	0.89	1.17	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.